CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 3,932 shares at $35.94 ($141,316)
- 4 Open-market sale Chief Executive Officer sold 10,031 shares at $41.23 ($413,578)
- 4 Open-market sale Chief Operating Officer sold 1,714 shares at $41.23 ($70,668)
- 4 Open-market sale Chief Financial Officer sold 2,197 shares at $41.23 ($90,582)
- 4 Open-market sale General Counsel and Secretary sold 3,185 shares at $41.23 ($131,318)
- 4 Derivatives Options or other derivatives
Page 4 of 26 · 502 filings